G W Basak
Overview
Explore the profile of G W Basak including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
14
Citations
326
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Hayden P, Roddie C, Bader P, Basak G, Bonig H, Bonini C, et al.
Ann Oncol
. 2021 Dec;
33(3):259-275.
PMID: 34923107
Background: Several commercial and academic autologous chimeric antigen receptor T-cell (CAR-T) products targeting CD19 have been approved in Europe for relapsed/refractory B-cell acute lymphoblastic leukemia, high-grade B-cell lymphoma and mantle...
2.
Ros-Soto J, Snowden J, Salooja N, Gilleece M, Parker A, Greenfield D, et al.
Biol Blood Marrow Transplant
. 2019 Jun;
25(10):2079-2085.
PMID: 31229642
Beyond its impact on bone health, numerous studies have investigated the immune-regulatory properties of vitamin D and shown how its deficiency can affect outcomes in allogeneic hematopoietic stem cell transplantation...
3.
Chabannon C, Kuball J, McGrath E, Bader P, Dufour C, Lankester A, et al.
Bone Marrow Transplant
. 2017 Dec;
52(12):1588-1589.
PMID: 29209061
No abstract available.
4.
Drozd-Sokolowska J, Gil L, Waszczuk-Gajda A, Madry K, Piekarska A, Dutka M, et al.
Transplant Proc
. 2016 Aug;
48(5):1802-5.
PMID: 27496495
Background: Relapse of primary hematologic disease constitutes an important reason for failure of allogeneic hematopoietic stem cell transplantation (alloHSCT). There are very few treatment modalities for this indications. Therefore, there...
5.
Drozd-Sokolowska J, Sokolowski J, Biecek P, Niemczyk K, Basak G, Wiktor-Jedrzejczak W
Transplant Proc
. 2016 Aug;
48(5):1797-801.
PMID: 27496494
Background: Although rhinosinusitis constitutes a major clinical problem in general population, data on rhinosinusitis in patients undergoing allogeneic hematopoietic stem cell transplantation (alloHSCT) are scarce. Therefore, the aim of the...
6.
Abdelbaset-Ismail A, Borkowska-Rzeszotek S, Kubis E, Bujko K, Brzezniakiewicz-Janus K, Bolkun L, et al.
Leukemia
. 2016 Jul;
31(2):446-458.
PMID: 27451975
As a crucial arm of innate immunity, the complement cascade (ComC) is involved both in mobilization of normal hematopoietic stem/progenitor cells (HSPCs) from bone marrow (BM) into peripheral blood and...
7.
Inamoto Y, Shah N, Savani B, Shaw B, Abraham A, Ahmed I, et al.
Bone Marrow Transplant
. 2015 Mar;
50(8):1013-23.
PMID: 25822223
Hematopoietic stem cell transplant (HCT) recipients have a substantial risk of developing secondary solid cancers, particularly beyond 5 years after HCT and without reaching a plateau overtime. A working group...
8.
Basak G, Wiktor-Jedrzejczak W, Labopin M, Schoemans H, Ljungman P, Kobbe G, et al.
Am J Transplant
. 2015 Feb;
15(3):705-14.
PMID: 25648262
We conducted a questionnaire survey of the 565 European Society for Blood and Marrow Transplantation centers to analyze the outcome of allogeneic hematopoietic stem cell transplantation (alloSCT) in recipients of...
9.
Mohty M, Hubel K, Kroger N, Aljurf M, Apperley J, Basak G, et al.
Bone Marrow Transplant
. 2014 Apr;
49(7):865-72.
PMID: 24686988
Autologous haematopoietic SCT with PBSCs is regularly used to restore BM function in patients with multiple myeloma or lymphoma after myeloablative chemotherapy. Twenty-eight experts from the European Group for Blood...
10.
Basak G, de Wreede L, van Biezen A, Wiktor-Jedrzejczak W, Halaburda K, Schmid C, et al.
Bone Marrow Transplant
. 2012 Nov;
48(6):837-42.
PMID: 23178548
Peripheral blood used as a source of stem cells for transplantation (PBSCT) is known to exert stronger immune-mediated effects compared with BM (BMT). We decided to retrospectively analyze the impact...